Pharma Pushes For Stronger ‘March In’ Rule Despite Changing Political Dynamics, COVID Complications

 
• By Sarah Karlin-Smith
  
patent license agreement
The Biden administration will have to review more than 80,000 comments on a proposed rule impacting patent rights • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet